Clinical Trial

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Name: Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia — clinical trial record (NCT06762548)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Clinical Study of DA-007 As a Treatment for Chemotherapy Induced Alopecia

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-01-06; most recent amendment 2025-05-22.

Trial Details

NCT Number	NCT06762548
Lead Sponsor	Applied Biology, Inc. Collaborators: Daniel Alain, Inc., Follea International Limited
Conditions	Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Enrollment	140 participants
Start Date	2025-10-10
Primary Completion	2026-09-11 (estimated)
Study Completion	2026-11-06 (estimated)
Updated on ClinicalTrials.gov	2025-05-23